Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Other Non Operating Income (2014 - 2026)

Updated

Theravance Biopharma's Other Non Operating Income came in at $3.49 million for Q2 2026, up 139.3% from $1.46 million a year earlier and up 15.7% from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Other Non Operating Income (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Theravance Biopharma reported Other Non Operating Income of $14.28 million, up 202.8% year-over-year; for FY2025, it came in at $10.17 million, up 108.4% from FY2024.

  • Other Non Operating Income carries a five-year compound annual growth rate of 29.2% (FY2020 to FY2025).
  • Going back by year, Other Non Operating Income was $4.88 million in FY2024 (-46.5%), $9.12 million in FY2023 (+6.7%), $8.55 million in FY2022 (+670.5%) and $1.11 million in FY2021 (-60.8%).
  • The five-year range for quarterly Other Non Operating Income is -$3.03 million (Q3 2022) to $4.14 million (Q3 2025).
  • Year-over-year, Other Non Operating Income has increased for five consecutive quarters, with growth averaging 97.3% over the last eight quarters.
  • The fastest year-over-year change in Other Non Operating Income over five years came in Q4 2025 (growth of 302.5%), and the weakest in Q4 2021 (a decline of 98.2%).
  • Business Quant data shows TBPH's Other Non Operating Income at $3.01 million (Q1 2026), $3.64 million (Q4 2025) and $4.14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.49 Mn
Mar 31, 2026 3.01 Mn
Dec 31, 2025 3.64 Mn
Sep 30, 2025 4.14 Mn
Jun 30, 2025 1.46 Mn
Mar 31, 2025 939,000.00
Dec 31, 2024 904,000.00
Sep 30, 2024 1.42 Mn
Jun 30, 2024 1.13 Mn
Mar 31, 2024 1.43 Mn
Dec 31, 2023 1.85 Mn
Sep 30, 2023 1.79 Mn
Jun 30, 2023 2.50 Mn
Mar 31, 2023 2.98 Mn
Dec 31, 2022 3.72 Mn
Sep 30, 2022 -3.03 Mn
Jun 30, 2022 2.44 Mn
Mar 31, 2022 -375,000.00
Dec 31, 2021 338,000.00
Sep 30, 2021 -166,000.00
API Access

Theravance Biopharma Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TBPH&period=max&api_key=YOUR_API_KEY